303 related articles for article (PubMed ID: 31969175)
1. Addressing low-value pharmacological prescribing in primary prevention of CVD through a structured evidence-based and theory-informed process for the design and testing of de-implementation strategies: the DE-imFAR study.
Sanchez A; Pijoan JI; Pablo S; Mediavilla M; de Rozas RS; Lekue I; Gonzalez-Larragan S; Lantaron G; Argote J; García-Álvarez A; Latorre PM; Helfrich CD; Grandes G
Implement Sci; 2020 Jan; 15(1):8. PubMed ID: 31969175
[TBL] [Abstract][Full Text] [Related]
2. Applying the behavior change wheel to design de-implementation strategies to reduce low-value statin prescription in primary prevention of cardiovascular disease in primary care.
Sanchez A; Elizondo-Alzola U; Pijoan JI; Mediavilla MM; Pablo S; Sainz de Rozas R; Lekue I; Gonzalez-Larragan S; Llarena M; Larrañaga O; Helfrich CD; Grandes G
Front Med (Lausanne); 2022; 9():967887. PubMed ID: 36314033
[TBL] [Abstract][Full Text] [Related]
3. De-imFAR phase II project: a study protocol for a cluster randomised implementation trial to evaluate the effectiveness of de-implementation strategies to reduce low-value statin prescribing in the primary prevention of cardiovascular disease.
Sanchez A; Pijoan JI; Sainz de Rozas R; Lekue I; San Vicente R; Quindimil JA; Rotaeche R; Etxeberria A; Mozo C; Martinez-Cengotitabengoa M; Monge M; Gómez-Ramírez C; Samper R; Ogueta Lana M; Celorrio S; Merino-Inda N; Llarena M; Gonzalez Saenz de Tejada M; García-Alvarez A; Grandes G
BMJ Open; 2024 Apr; 14(4):e078692. PubMed ID: 38631840
[TBL] [Abstract][Full Text] [Related]
4. De-implementation of low value castration for men with prostate cancer: protocol for a theory-based, mixed methods approach to minimizing low value androgen deprivation therapy (DeADT).
Skolarus TA; Hawley ST; Wittmann DA; Forman J; Metreger T; Sparks JB; Zhu K; Caram MEV; Hollenbeck BK; Makarov DV; Leppert JT; Shelton JB; Shahinian V; Srinivasaraghavan S; Sales AE
Implement Sci; 2018 Nov; 13(1):144. PubMed ID: 30486836
[TBL] [Abstract][Full Text] [Related]
5. Promoting de-implementation of inappropriate antimicrobial use in cardiac device procedures by expanding audit and feedback: protocol for hybrid III type effectiveness/implementation quasi-experimental study.
Branch-Elliman W; Lamkin R; Shin M; Mull HJ; Epshtein I; Golenbock S; Schweizer ML; Colborn K; Rove J; Strymish JM; Drekonja D; Rodriguez-Barradas MC; Xu TH; Elwy AR
Implement Sci; 2022 Jan; 17(1):12. PubMed ID: 35093104
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Implementing cardiovascular disease prevention guidelines to translate evidence-based medicine and shared decision making into general practice: theory-based intervention development, qualitative piloting and quantitative feasibility.
Bonner C; Fajardo MA; Doust J; McCaffery K; Trevena L
Implement Sci; 2019 Aug; 14(1):86. PubMed ID: 31466526
[TBL] [Abstract][Full Text] [Related]
8. A mixed methods protocol for developing and testing implementation strategies for evidence-based obesity prevention in childcare: a cluster randomized hybrid type III trial.
Swindle T; Johnson SL; Whiteside-Mansell L; Curran GM
Implement Sci; 2017 Jul; 12(1):90. PubMed ID: 28720140
[TBL] [Abstract][Full Text] [Related]
9. A randomized matched-pairs study of feasibility, acceptability, and effectiveness of systems consultation: a novel implementation strategy for adopting clinical guidelines for Opioid prescribing in primary care.
Quanbeck A; Brown RT; Zgierska AE; Jacobson N; Robinson JM; Johnson RA; Deyo BM; Madden L; Tuan WJ; Alagoz E
Implement Sci; 2018 Jan; 13(1):21. PubMed ID: 29370813
[TBL] [Abstract][Full Text] [Related]
10. Discontinuing statins or not in the elderly? Study protocol for a randomized controlled trial.
Bonnet F; Bénard A; Poulizac P; Afonso M; Maillard A; Salvo F; Berdaï D; Salles N; Rousselot N; Marchi S; Hayes N; Joseph JP
Trials; 2020 Apr; 21(1):342. PubMed ID: 32307005
[TBL] [Abstract][Full Text] [Related]
11. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
12. Engaging primary care professionals in collaborative processes for optimising type 2 diabetes prevention practice: the PREDIAPS cluster randomised type II hybrid implementation trial.
Sanchez A; Grandes G; Pablo S; Espinosa M; Torres A; García-Alvarez A;
Implement Sci; 2018 Jul; 13(1):94. PubMed ID: 29996928
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the implementation of an integrated primary care network for prevention and management of cardiometabolic risk in Montréal.
Provost S; Pineault R; Tousignant P; Hamel M; Da Silva RB
BMC Fam Pract; 2011 Nov; 12():126. PubMed ID: 22074614
[TBL] [Abstract][Full Text] [Related]
14. A Polypill for primary prevention of cardiovascular disease: a feasibility study of the World Health Organization.
Soliman EZ; Mendis S; Dissanayake WP; Somasundaram NP; Gunaratne PS; Jayasingne IK; Furberg CD
Trials; 2011 Jan; 12():3. PubMed ID: 21205325
[TBL] [Abstract][Full Text] [Related]
15. Cohort study investigating the relationship between cholesterol, cardiovascular risk score and the prescribing of statins in UK primary care: study protocol.
Finnikin S; Ryan R; Marshall T
BMJ Open; 2016 Nov; 6(11):e013120. PubMed ID: 27856481
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of de-implementation strategies for low-value prescribing in secondary care: a systematic review.
Dunsmore J; Duncan E; MacLennan S; N'Dow J; MacLennan S
Implement Sci Commun; 2023 Sep; 4(1):115. PubMed ID: 37723589
[TBL] [Abstract][Full Text] [Related]
17. The efficiency of cardiovascular risk assessment: do the right patients get statin treatment?
van Staa TP; Smeeth L; Ng ES; Goldacre B; Gulliford M
Heart; 2013 Nov; 99(21):1597-602. PubMed ID: 23735939
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of two statin prescribing strategies with respect to adherence and cardiovascular outcomes: observational study.
Wei L; MacDonald TM; Watson AD; Murphy MJ
Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):385-92. PubMed ID: 16998946
[TBL] [Abstract][Full Text] [Related]
19. Study protocol for a type III hybrid effectiveness-implementation trial of strategies to implement firearm safety promotion as a universal suicide prevention strategy in pediatric primary care.
Beidas RS; Ahmedani BK; Linn KA; Marcus SC; Johnson C; Maye M; Westphal J; Wright L; Beck AL; Buttenheim AM; Daley MF; Davis M; Elias ME; Jager-Hyman S; Hoskins K; Lieberman A; McArdle B; Ritzwoller DP; Small DS; Wolk CB; Williams NJ; Boggs JM
Implement Sci; 2021 Sep; 16(1):89. PubMed ID: 34551811
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
